End-of-day quote
Taipei Exchange
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
187.5
TWD
|
-1.32%
|
|
+3.31%
|
-1.32%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
22,914
|
14,117
|
15,806
|
12,428
|
9,579
|
9,453
|
-
|
Enterprise Value (EV)
1 |
21,804
|
13,259
|
14,346
|
10,736
|
9,579
|
7,738
|
7,249
|
P/E ratio
|
17.9
x
|
19.1
x
|
16.8
x
|
12.3
x
|
17.5
x
|
14
x
|
-
|
Yield
|
3.96%
|
4.29%
|
4.78%
|
5.48%
|
-
|
4.8%
|
6.4%
|
Capitalization / Revenue
|
3.61
x
|
2.82
x
|
2.93
x
|
2.48
x
|
2.18
x
|
1.96
x
|
1.91
x
|
EV / Revenue
|
3.44
x
|
2.65
x
|
2.66
x
|
2.15
x
|
2.18
x
|
1.6
x
|
1.47
x
|
EV / EBITDA
|
10.9
x
|
9.97
x
|
9.25
x
|
7.66
x
|
10.3
x
|
6.73
x
|
5.12
x
|
EV / FCF
|
20
x
|
16.4
x
|
12.4
x
|
9.31
x
|
-
|
10.4
x
|
7.34
x
|
FCF Yield
|
5%
|
6.08%
|
8.1%
|
10.7%
|
-
|
9.6%
|
13.6%
|
Price to Book
|
3.98
x
|
2.51
x
|
2.65
x
|
1.98
x
|
-
|
1.46
x
|
1.4
x
|
Nbr of stocks (in thousands)
|
50,417
|
50,417
|
50,417
|
50,417
|
50,417
|
50,417
|
-
|
Reference price
2 |
454.5
|
280.0
|
313.5
|
246.5
|
190.0
|
187.5
|
187.5
|
Announcement Date
|
3/17/20
|
3/17/21
|
3/22/22
|
3/25/23
|
3/14/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
6,347
|
5,007
|
5,402
|
5,003
|
4,394
|
4,822
|
4,941
|
EBITDA
1 |
2,009
|
1,330
|
1,551
|
1,401
|
927.7
|
1,150
|
1,417
|
EBIT
1 |
1,650
|
1,001
|
1,231
|
1,073
|
605.7
|
868.1
|
1,065
|
Operating Margin
|
25.99%
|
19.99%
|
22.79%
|
21.44%
|
13.79%
|
18%
|
21.55%
|
Earnings before Tax (EBT)
1 |
1,615
|
941.3
|
1,154
|
1,281
|
678.9
|
845
|
-
|
Net income
1 |
1,287
|
745.1
|
947.8
|
1,019
|
546
|
676
|
-
|
Net margin
|
20.28%
|
14.88%
|
17.55%
|
20.37%
|
12.43%
|
14.02%
|
-
|
EPS
2 |
25.37
|
14.68
|
18.67
|
20.05
|
10.83
|
13.44
|
-
|
Free Cash Flow
1 |
1,090
|
806.1
|
1,162
|
1,153
|
-
|
743
|
987
|
FCF margin
|
17.17%
|
16.1%
|
21.5%
|
23.05%
|
-
|
15.41%
|
19.98%
|
FCF Conversion (EBITDA)
|
54.25%
|
60.59%
|
74.87%
|
82.31%
|
-
|
64.61%
|
69.65%
|
FCF Conversion (Net income)
|
84.65%
|
108.19%
|
122.55%
|
113.17%
|
-
|
109.91%
|
-
|
Dividend per Share
2 |
18.00
|
12.00
|
15.00
|
13.50
|
-
|
9.000
|
12.00
|
Announcement Date
|
3/17/20
|
3/17/21
|
3/22/22
|
3/25/23
|
3/14/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
1,425
|
1,327
|
1,346
|
1,225
|
1,287
|
1,146
|
1,131
|
1,074
|
1,054
|
1,134
|
1,086
|
1,133
|
1,192
|
1,260
|
EBITDA
|
433.4
|
376.2
|
381.3
|
-
|
352
|
323.4
|
278.9
|
218.2
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
354
|
296
|
299.2
|
261.7
|
270.5
|
241.3
|
197.9
|
136.9
|
84.92
|
186
|
173
|
182.8
|
221.7
|
246
|
Operating Margin
|
24.84%
|
22.3%
|
22.23%
|
21.36%
|
21.02%
|
21.06%
|
17.49%
|
12.74%
|
8.06%
|
16.39%
|
15.93%
|
16.13%
|
18.6%
|
19.53%
|
Earnings before Tax (EBT)
1 |
354.1
|
275.2
|
370.8
|
309.4
|
377.3
|
223.6
|
200.6
|
188.7
|
158.1
|
-
|
179
|
208
|
217
|
240
|
Net income
1 |
283.3
|
226.8
|
296.6
|
241.8
|
301.9
|
178.8
|
163
|
138
|
137.9
|
107.1
|
143
|
166
|
174
|
192
|
Net margin
|
19.88%
|
17.08%
|
22.04%
|
19.73%
|
23.46%
|
15.6%
|
14.4%
|
12.85%
|
13.08%
|
9.44%
|
13.17%
|
14.65%
|
14.6%
|
15.24%
|
EPS
2 |
5.590
|
4.450
|
5.840
|
4.780
|
5.950
|
3.520
|
3.230
|
2.730
|
2.730
|
2.130
|
2.850
|
3.300
|
3.450
|
3.810
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/3/21
|
3/22/22
|
5/5/22
|
8/4/22
|
11/3/22
|
3/25/23
|
5/3/23
|
8/2/23
|
11/1/23
|
3/14/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,110
|
857
|
1,460
|
1,691
|
-
|
1,715
|
2,204
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,090
|
806
|
1,162
|
1,153
|
-
|
743
|
987
|
ROE (net income / shareholders' equity)
|
22.3%
|
13.1%
|
16.3%
|
16.7%
|
-
|
11.2%
|
12.6%
|
ROA (Net income/ Total Assets)
|
15%
|
9.05%
|
11.4%
|
12.1%
|
-
|
8.5%
|
10.7%
|
Assets
1 |
8,582
|
8,231
|
8,322
|
8,451
|
-
|
7,953
|
-
|
Book Value Per Share
2 |
114.0
|
112.0
|
118.0
|
124.0
|
-
|
128.0
|
134.0
|
Cash Flow per Share
|
27.10
|
16.70
|
24.40
|
25.30
|
-
|
-
|
-
|
Capex
1 |
284
|
40.5
|
78.3
|
135
|
-
|
162
|
162
|
Capex / Sales
|
4.47%
|
0.81%
|
1.45%
|
2.7%
|
-
|
3.36%
|
3.28%
|
Announcement Date
|
3/17/20
|
3/17/21
|
3/22/22
|
3/25/23
|
3/14/24
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
187.5
TWD Average target price
197
TWD Spread / Average Target +5.07% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.32% | 294M | | +8.32% | 38.89B | | -5.87% | 17.87B | | -16.61% | 2.37B | | -16.74% | 1.48B | | +32.16% | 1.24B | | -34.97% | 761M | | -35.01% | 738M | | -7.58% | 672M | | +25.66% | 509M |
Glasses, Spectacles & Contact Lenses
|